Guardant Health
GH
#1003
Rank
โ‚น2.297 T
Marketcap
โ‚น17,122
Share price
1.75%
Change (1 day)
206.92%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -โ‚น41.75 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚น1.18 Billion. In 2025 the company made an earning of -โ‚น40.21 Billion, an increase over its 2024 earnings that were of -โ‚น41.9 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น41.75 Billion3.82%
2025 -โ‚น40.21 Billion-4.03%
2024 -โ‚น41.9 Billion-9.12%
2023 -โ‚น46.11 Billion-26.73%
2022 -โ‚น62.93 Billion69.96%
2021 -โ‚น37.03 Billion56.35%
2020 -โ‚น23.69 Billion252.69%
2019 -โ‚น6.72 Billion-17.22%
2018 -โ‚น8.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-โ‚น0.87 Billion-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น24.34 Billion-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA